发明名称 Glucocorticoid receptor agonist comprising novel 1,2,3,4-tetrahydroquinoxaline derivative containing phenyl group having sulfonic acid ester structure introduced therein as substituent
摘要 The object aims to find a novel pharmacological activity of a novel 1,2,3,4-tetrahydroquinoxaline derivative which contains, as a substituent, a phenyl group having a sulfonic acid ester structure introduced therein. A compound represented by general formula (1) or a salt thereof is useful as a glucocorticoid receptor agonist, particularly as a therapeutic agent for diseases against which a glucocorticoid receptor agonist (e.g., a steroid) is believed to be effective, such as inflammatory bone/joint diseases, inflammatory ophthalmic diseases (inflammatory ophthalmic diseases in the anterior or posterior segment of an eye). R 1 represents a group represented by general formula (2a), (3a), (4a) or (5a); R 2 represents a lower alkyl group which may have a substituent, a lower cycloalkyl group which may have a substituent, or the like; R 3 represents a lower alkyl group; R 4 , R 5 , R 6 or R 7 represent a halogen atom, a lower alkyl group which may have a substituent, a hydroxy group, a lower alkoxy group which may have a substituent, or the like; and m, n, p or q represents a number of 0, 1 or 2.
申请公布号 AU2009292437(A1) 申请公布日期 2010.03.18
申请号 AU20090292437 申请日期 2009.09.11
申请人 SANTEN PHARMACEUTICAL CO., LTD. 发明人 MASATOMO KATO;MIWA TAKAI;TAKAHIRO MATSUYAMA;TATSUJI KUROSE;YUMI HAGIWARA;KENJI OKI;MAMORU MATSUDA;TOSHIYUKI MORI
分类号 C07D241/44;A61K31/498;A61K31/5377;A61P27/02;A61P29/00;C07D409/12 主分类号 C07D241/44
代理机构 代理人
主权项
地址